TANDEM DIABETES CARE INC Quarterly Deferred Income Tax Expense (Benefit) in USD from Q4 2021 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Tandem Diabetes Care Inc annual/quarterly Deferred Income Tax Expense (Benefit) history and growth rate from Q4 2021 to Q4 2022.
  • Tandem Diabetes Care Inc Deferred Income Tax Expense (Benefit) for the quarter ending December 31, 2022 was $0.000.
  • Tandem Diabetes Care Inc annual Deferred Income Tax Expense (Benefit) for 2023 was $0.000.
  • Tandem Diabetes Care Inc annual Deferred Income Tax Expense (Benefit) for 2022 was $0.000.
  • Tandem Diabetes Care Inc annual Deferred Income Tax Expense (Benefit) for 2021 was $0.000.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 $0 $0 Oct 1, 2022 Dec 31, 2022 10-K 2023-02-22
Q4 2021 $0 Oct 1, 2021 Dec 31, 2021 10-K 2023-02-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.